These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 33208860)

  • 1. Gestational perfluoroalkyl substance exposure and body mass index trajectories over the first 12 years of life.
    Braun JM; Eliot M; Papandonatos GD; Buckley JP; Cecil KM; Kalkwarf HJ; Chen A; Eaton CB; Kelsey K; Lanphear BP; Yolton K
    Int J Obes (Lond); 2021 Jan; 45(1):25-35. PubMed ID: 33208860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Variability of perfluoroalkyl substance concentrations in pregnant women by socio-demographic and dietary factors in a Spanish birth cohort.
    Manzano-Salgado CB; Casas M; Lopez-Espinosa MJ; Ballester F; Martinez D; Ibarluzea J; Santa-Marina L; Schettgen T; Vioque J; Sunyer J; Vrijheid M
    Environ Int; 2016; 92-93():357-65. PubMed ID: 27132161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prenatal Exposure to Perfluoroalkyl Substances and Cardiometabolic Risk in Children from the Spanish INMA Birth Cohort Study.
    Manzano-Salgado CB; Casas M; Lopez-Espinosa MJ; Ballester F; Iñiguez C; Martinez D; Romaguera D; Fernández-Barrés S; Santa-Marina L; Basterretxea M; Schettgen T; Valvi D; Vioque J; Sunyer J; Vrijheid M
    Environ Health Perspect; 2017 Sep; 125(9):097018. PubMed ID: 28934720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prenatal exposure to perfluoroalkyl substances and birth outcomes in a Spanish birth cohort.
    Manzano-Salgado CB; Casas M; Lopez-Espinosa MJ; Ballester F; Iñiguez C; Martinez D; Costa O; Santa-Marina L; Pereda-Pereda E; Schettgen T; Sunyer J; Vrijheid M
    Environ Int; 2017 Nov; 108():278-284. PubMed ID: 28917208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gestational and childhood exposure to per- and polyfluoroalkyl substances and cardiometabolic risk at age 12 years.
    Li N; Liu Y; Papandonatos GD; Calafat AM; Eaton CB; Kelsey KT; Cecil KM; Kalkwarf HJ; Yolton K; Lanphear BP; Chen A; Braun JM
    Environ Int; 2021 Feb; 147():106344. PubMed ID: 33418195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prenatal exposure to perfluoroalkyl substances and associations with symptoms of attention-deficit/hyperactivity disorder and cognitive functions in preschool children.
    Skogheim TS; Villanger GD; Weyde KVF; Engel SM; Surén P; Øie MG; Skogan AH; Biele G; Zeiner P; Øvergaard KR; Haug LS; Sabaredzovic A; Aase H
    Int J Hyg Environ Health; 2020 Jan; 223(1):80-92. PubMed ID: 31653559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of perfluoroalkyl exposure in pregnancy and infancy on intrauterine and childhood growth and anthropometry. Sub study from COPSAC2010 birth cohort.
    Sevelsted A; Gürdeniz G; Rago D; Pedersen CT; Lasky-Su JA; Checa A; Zhang P; Wheelock CE; Normann SS; Kristensen DM; Rasmussen MA; Schullehner J; Sdougkou K; Martin JW; Stokholm J; Bønnelykke K; Bisgaard H; Chawes B
    EBioMedicine; 2022 Sep; 83():104236. PubMed ID: 36030647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Associations of Gestational Perfluoroalkyl Substances Exposure with Early Childhood BMI
    Liu Y; Wosu AC; Fleisch AF; Dunlop AL; Starling AP; Ferrara A; Dabelea D; Oken E; Buckley JP; Chatzi L; Karagas MR; Romano ME; Schantz S; O'Connor TG; Woodruff TJ; Zhu Y; Hamra GB; Braun JM;
    Environ Health Perspect; 2023 Jun; 131(6):67001. PubMed ID: 37283528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prenatal and childhood perfluoroalkyl substances exposures and children's reading skills at ages 5 and 8years.
    Zhang H; Yolton K; Webster GM; Ye X; Calafat AM; Dietrich KN; Xu Y; Xie C; Braun JM; Lanphear BP; Chen A
    Environ Int; 2018 Feb; 111():224-231. PubMed ID: 29241079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prenatal Exposures to Perfluoroalkyl Acids and Associations with Markers of Adiposity and Plasma Lipids in Infancy: An Odense Child Cohort Study.
    Jensen RC; Andersen MS; Larsen PV; Glintborg D; Dalgård C; Timmermann CAG; Nielsen F; Sandberg MB; Andersen HR; Christesen HT; Grandjean P; Jensen TK
    Environ Health Perspect; 2020 Jul; 128(7):77001. PubMed ID: 32628516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prenatal perfluoroalkyl substances and newborn anogenital distance in a Canadian cohort.
    Arbuckle TE; MacPherson S; Foster WG; Sathyanarayana S; Fisher M; Monnier P; Lanphear B; Muckle G; Fraser WD
    Reprod Toxicol; 2020 Jun; 94():31-39. PubMed ID: 32283250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Associations of Prenatal Per- and Polyfluoroalkyl Substance (PFAS) Exposures with Offspring Adiposity and Body Composition at 16-20 Years of Age: Project Viva.
    Zhang M; Rifas-Shiman SL; Aris IM; Fleisch AF; Lin PD; Nichols AR; Oken E; Hivert MF
    Environ Health Perspect; 2023 Dec; 131(12):127002. PubMed ID: 38054701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prenatal exposure to persistent organic pollutants and child overweight/obesity at 5-year follow-up: a prospective cohort study.
    Lauritzen HB; Larose TL; Øien T; Sandanger TM; Odland JØ; van de Bor M; Jacobsen GW
    Environ Health; 2018 Jan; 17(1):9. PubMed ID: 29347948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prenatal exposure to legacy PFAS and neurodevelopment in preschool-aged Canadian children: The MIREC cohort.
    Goodman CV; Till C; Green R; El-Sabbagh J; Arbuckle TE; Hornung R; Lanphear B; Seguin JR; Booij L; Fisher M; Muckle G; Bouchard MF; Ashley-Martin J
    Neurotoxicol Teratol; 2023; 98():107181. PubMed ID: 37178772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Per- and polyfluoroalkyl substances, gestational weight gain, postpartum weight retention and body composition in the UPSIDE cohort.
    Kinkade CW; Rivera-Núñez Z; Thurston SW; Kannan K; Miller RK; Brunner J; Wong E; Groth S; O'Connor TG; Barrett ES
    Environ Health; 2023 Sep; 22(1):61. PubMed ID: 37658449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maternal serum concentrations of perfluoroalkyl substances during pregnancy and gestational weight gain: The Avon Longitudinal Study of Parents and Children.
    Marks KJ; Jeddy Z; Flanders WD; Northstone K; Fraser A; Calafat AM; Kato K; Hartman TJ
    Reprod Toxicol; 2019 Dec; 90():8-14. PubMed ID: 31415809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prenatal perfluoroalkyl substance exposure and child adiposity at 8 years of age: The HOME study.
    Braun JM; Chen A; Romano ME; Calafat AM; Webster GM; Yolton K; Lanphear BP
    Obesity (Silver Spring); 2016 Jan; 24(1):231-7. PubMed ID: 26554535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. No association between maternal and child PFAS concentrations and repeated measures of ADHD symptoms at age 2½ and 5 years in children from the Odense Child Cohort.
    Dalsager L; Jensen TK; Nielsen F; Grandjean P; Bilenberg N; Andersen HR
    Neurotoxicol Teratol; 2021; 88():107031. PubMed ID: 34563660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prenatal Exposure to Perfluoroalkyl Substances and Adiposity in Early and Mid-Childhood.
    Mora AM; Oken E; Rifas-Shiman SL; Webster TF; Gillman MW; Calafat AM; Ye X; Sagiv SK
    Environ Health Perspect; 2017 Mar; 125(3):467-473. PubMed ID: 27352404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prenatal exposure to per- and polyfluoroalkyl substances and infant growth and adiposity: the Healthy Start Study.
    Starling AP; Adgate JL; Hamman RF; Kechris K; Calafat AM; Dabelea D
    Environ Int; 2019 Oct; 131():104983. PubMed ID: 31284113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.